UPDATE: BMO Capital Starts Vertex (VRTX) at Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Vertex Pharma (VRTX) Enters Reimbursement Agreement in Spain for KAFTRIO in Combination With Ivacaftor
November 19, 2021 6:04 AM ESTVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Spanish government has approved terms for the... More
Piper Sandler Downgrades Vertex (VRTX) to Neutral
November 18, 2021 4:09 PM ESTPiper Sandler analyst Do Kim downgraded Vertex (NASDAQ: VRTX) from Overweight to Neutral with a price target of $218.00 (from $323.00).
For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.
Shares of Vertex closed at $188.25 yesterday.
... MoreTruist Provides Follow Up Abbvie (ABBV) Triple Data
November 17, 2021 10:24 AM ESTTruist Securities analyst Robyn Karnauskas had a follow up on Abbvie (NYSE: ABBV) after taking to management. The trial is on track for internal readouts, while the data release timings under debate.
Company remains on track to see POC data... MoreVertex Pharma (VRTX) Sees Early Gains, Possible on Competitor Delay
November 17, 2021 9:40 AM ESTVertex Pharma (NASDAQ: VRTX) strength could be tied to a possible delay with AbbVie (NYSE: ABBV) triple Phase 2 trial for CF. Shares up 3.2%.
... More